Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $608.9100 (-3.32%) ($596.0150 - $623.7000) on Fri. Jul. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 46 | Latest Price | $608.9100(-3.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.3% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $629.4 | 5 Day Moving Average | $634.57(-4.04%) | 10 Day Moving Average | $633.62(-3.9%) | 20 Day Moving Average | $629.4(-3.26%) | To recent high | -7.5% | To recent low | 18.1% | Market Cap | $64.562b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |